PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1887037
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1887037
The global ophthalmic ultrasound market is witnessing steady expansion driven by rising eye-related disorders, technological innovation, and the introduction of advanced ocular diagnostic devices. As reported in 2024, the market size reached USD 283.9 million, with projections indicating growth to USD 303.7 million in 2025, and eventually USD 499.6 million by 2032. This reflects a strong CAGR of 7.4% from 2025 to 2032, signaling sustained long-term demand for ophthalmic imaging technologies.
Ophthalmic ultrasound devices support ophthalmologists in visualizing the internal structures of the eye, including the retina, orbit, vitreous, and anterior segment. These imaging tools play a critical role in diagnosing glaucoma, diabetic retinopathy, vitreous hemorrhage, tumors, and trauma-related ocular complications. Rising global cases of hyperopia, cataracts, and glaucoma are boosting the need for accurate diagnostic instruments. For instance, Crystal Vision Ltd. estimated that 30.6% of adults worldwide will suffer from hyperopia by the end of 2025, emphasizing the need for early detection technologies.
North America Leads with 42.40% Market Share in 2024
North America dominated the global market in 2024 with a 42.40% share, generating USD 120.4 million in revenue. The region's leadership is attributed to advanced healthcare infrastructure, widespread clinical adoption of imaging tools, and increased prevalence of various ocular diseases. According to CDC data from 2024, 4.2 million people in the U.S. were living with glaucoma, including 1.5 million individuals with vision-affecting glaucoma. The high disease burden strengthens demand for ophthalmic diagnostic devices across clinical settings. Active participation of companies such as Micro Medical Devices (MMD), Keeler, and NIDEK at medical expos and conferences also contributes to increased product visibility and adoption.
Market Drivers: Growing Burden of Eye Disorders
Global incidences of hyperopia, glaucoma, AMD, and diabetic retinopathy continue to rise, creating an urgent need for ophthalmic ultrasound systems capable of early detection. Hyperopia alone is projected to impact 37.2% of adults in America and 23.1% in Europe by the end of 2025, according to Crystal Vision Ltd. These conditions require precise imaging for both diagnosis and surgical planning, and ophthalmic ultrasound remains a crucial tool toward effective disease management.
Market Restraints: High Costs and Availability of Alternatives
Despite growing demand, the adoption of ophthalmic ultrasound systems is limited by high device costs, which typically range from USD 5,500 to USD 20,000. This restricts availability in lower-income regions and smaller medical establishments. Moreover, advanced imaging alternatives-such as Optical Coherence Tomography (OCT), fundus imaging, and MRI-are increasingly favored by clinicians for their sophisticated diagnostic capabilities. The launch of new OCT devices, such as NIDEK's RS-1 Glaucoma OCT system in June 2024, adds competitive pressure on traditional ultrasound methods.
Opportunities: Healthcare Infrastructure Expansion
Increasing establishment of ophthalmic clinics, eye hospitals, and specialized diagnostic centers worldwide provides new market opportunities. For example, the Gadigal Eye Clinic at Sydney Eye Hospital, launched in October 2024, expanded diagnostic capacity in Australia. Eye-care awareness programs, such as Glaucoma Awareness Week by LVPEI in March 2025, further encourage early screening and bolster demand for diagnostic ultrasound devices.
Technology Trends: Portable & 3D Ultrasound Devices Gain Traction
Technological advancements continue to shape the ophthalmic ultrasound market. Portable and handheld devices-such as Quantel Medical's Pocket III pachymeter launched in May 2024 and Keeler's 4Sight with A-Scan probe-are gaining popularity due to their mobility, accuracy, and ease of use. Meanwhile, 3D ultrasound imaging is emerging as a transformative trend, enhancing diagnostic precision and offering more comprehensive visualization for clinical decision-making.
Competitive Landscape
Major companies in the market include Keeler, HAI Laboratories, Micro Medical Devices (MMD), Lumibird Medical, NIDEK CO., LTD., Sonomed Escalon, and DGH Technology. Expansion strategies and manufacturing upgrades are key competitive factors. A notable development occurred in February 2025, when Keeler opened a new state-of-the-art manufacturing facility in Shanghai, strengthening localized production and supporting rising demand in China.
Segmentation By Product
By Device Type
By Imaging Type
By End-user
By Region